We performed the association analyses between TERT polymorphisms and grade 3 or 4 toxicity in advanced NSCLC patients during first-line platinum-based chemotherapy, however, no statistical significant association was observed. This evidence concerns the gene TERT and non-small cell lung carcinoma.